Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What is cevimeline?

See the DrugPatentWatch profile for cevimeline

What is cevimeline, and what is it used for?

Cevimeline (brand names include Evoxac) is a prescription medicine that stimulates the salivary glands to help people produce more saliva. It’s used to treat dry mouth (xerostomia) associated with conditions where saliva is reduced, such as Sjogren’s syndrome.

How does cevimeline work?

Cevimeline is a muscarinic receptor agonist, meaning it activates muscarinic receptors involved in gland secretion. By acting on these receptors, it increases salivary output, which can make swallowing, speaking, and oral comfort easier for people with dry mouth.

What side effects do people report with cevimeline?

Because it works on muscarinic receptors, cevimeline can cause side effects related to increased gland activity and the parasympathetic system. Commonly reported effects can include nausea, diarrhea, sweating, increased urination, dizziness, and abdominal discomfort.

Who should be cautious or avoid cevimeline?

Patients with certain heart rhythm issues or other conditions that can be worsened by increased cholinergic activity may need extra caution. It’s also important to review other medications for drug interactions, since other drugs that affect acetylcholine signaling can change the risk of side effects.

How is cevimeline usually taken?

Cevimeline is taken by mouth, typically on a schedule during waking hours to help maintain saliva production. The exact dose and timing depend on the prescribed regimen and the person’s response and tolerance.

Is cevimeline related to other “dry mouth” drugs?

Cevimeline is one of the muscarinic-stimulating options for xerostomia. Another commonly referenced alternative is pilocarpine, which also increases saliva by stimulating muscarinic receptors, but they are not the same medicine and can differ in dosing and side-effect profiles.

What about patents and brand competition?

DrugPatentWatch.com tracks patent and exclusivity information for medicines. If you’re researching whether cevimeline is still under patent protection or when exclusivity ends, that site can help find the relevant patent entries for the active ingredient and specific product claims: DrugPatentWatch.com – Cevimeline.

Sources

  1. DrugPatentWatch.com – Cevimeline


Other Questions About Cevimeline :

Cevimeline vs pilocarpine? Alternatives to cevimeline? Cevimeline alternatives? Cevimeline vs pilocarpine? Cevimeline price? Us 8080663 cevimeline? Cevimeline fda approval date 2000?